Drug design
Term · Chemistry · MLC-T-CHM-003446
The rational approach to discovering new therapeutic compounds by understanding the structure and function of a biological target. It involves creating molecules with specific properties to interact with a target, such as an enzyme or receptor, to produce a desired physiological effect. This process frequently uses computational methods like molecular docking and quantitative structure-activity relationship (QSAR) analysis to predict the binding affinity and activity of candidate molecules.
| Identifier | MLC-T-CHM-003446 |
|---|---|
| Field | Chemistry |
| Subject | Chemistry and Human Health |
| References | PAC, 1997, 69, 1137. 'Glossary of terms used in computational drug design (IUPAC Recommendations 1997)' on page 1142 (https://doi.org/10.1351/pac199769051137) |
| See also | Drug; Multivariate statistics; Pharmacokinetics; Toxicity |
Record as JSON
{
"id": "MLC-T-CHM-003446",
"term": "Drug design",
"field": "Chemistry",
"definition": "The rational approach to discovering new therapeutic compounds by understanding the structure and function of a biological target. It involves creating molecules with specific properties to interact with a target, such as an enzyme or receptor, to produce a desired physiological effect. This process frequently uses computational methods like molecular docking and quantitative structure-activity relationship (QSAR) analysis to predict the binding affinity and activity of candidate molecules.",
"subject": "Chemistry and Human Health",
"see_also": [
"drug",
"multivariate statistics",
"pharmacokinetics",
"toxicity"
],
"references": [
"PAC, 1997, 69, 1137. 'Glossary of terms used in computational drug design (IUPAC Recommendations 1997)' on page 1142 (https://doi.org/10.1351/pac199769051137)"
],
"url": "https://mlchart.com/terminology/chemistry/drug-design/"
}
Record 3,662 of 13,676 in Chemistry terminology (MLC-0109). Request the full dataset.